A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
Clinical trial NCT01959529 · COMPLETED
Trial details
- NCT number
- NCT01959529
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-29
- Primary completion
- 2016-10-16
- Enrollment
- 7637
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.